AMZN
Amazon.com, Inc.
AMZN has the edge over SAH overall, supported by stronger valuation and stronger modeled upside.
SAH
Sonic Automotive, Inc.
SAH offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SAH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
SAH's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SAH in the historical PE scenario, which offers more potential upside but is not a forecast.
SAH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.7x | $35.57 | -41% |
| Forward | 9.1x | $60.18 | — |
| Current | 9.6x | $60.18 | — |
| Fair | 11x | $66.57 | +11% |
| Expensive | 18x | $110 | +83% |
Historical ranges are pointers, not guarantees.
SAH's PE is in its fair range at 9.6x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SAH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect SAH's earnings to grow, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SAH in the latest year-over-year earnings comparison.
SAH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.62 | +6% |
| Q3 2026 | $6.25 | +69% |
SAH's earnings per share have climbed steadily: $6.25 over the past year, up 69% from the year before, and higher year over year every quarter since late 2026.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SAH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over SAH on profitability, with a higher operating margin.
SAH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | +0.4% |
| Q2 2026 | $3.9B | +7.6% |
| Q1 2026 | $3.7B | +1% |
| Q4 2025 | $3.9B | -0.6% |
SAH's revenue has held roughly level: $4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 3.4% | +4 points |
| Q1 2026 | 3.6% | -0.4 points |
| Q4 2025 | 3.2% | -0.3 points |
| Q3 2025 | 3.1% | N/A |
| Q2 2025 | -0.6% | N/A |
| Q1 2025 | 4% | N/A |
| Q4 2024 | 3.4% | N/A |
SAH's operating margin was 3.4% last quarter, up 4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SAH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$217.8M | -312% |
| Q1 2026 | -$1.5M | -101% |
| Q4 2025 | $329.4M | -22% |
SAH has the edge over AMZN in the latest year-over-year cash flow comparison.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over SAH on leverage, with a lower net debt burden relative to earnings.
SAH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 3.3x | Elevated |
| Q4 2025 | 3.0x | Elevated |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.5x | Moderate |
SAH's net debt is about 2.6 years of its operating earnings (EBITDA), about the same as a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SAH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 8.4 | Oversold |
SAH's weekly RSI is 37 (neutral) and its Stochastic is 8 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
SAH PE vs Consumer Cyclical Sector
| Metric | SAH | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 18x | 47% below |
| PE % | 36 | 47 | 11 pts below |
SAH has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over SAH on trend strength, trading above more of its moving averages.
SAH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.3 | 3.4% below |
| 20 week MA | $75.5 | 20% below |
| 50 week MA | $71.5 | 16% below |
| 100 week MA | $70.8 | 15% below |
| 200 week MA | $62.2 | 3.3% below |
SAH is in a downtrend: it's below all five of its weekly moving averages, and 3.3% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over SAH on returns for 2026, with the stronger performance.
SAH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.6 | $38.2 | +25% |
| 2021 | $38.2 | $48.3 | +27% |
| 2022 | $48.3 | $47.5 | -1.8% |
| 2023 | $47.5 | $56.2 | +18% |
| 2024 | $56.2 | $63.6 | +13% |
| 2025 | $63.6 | $64.3 | +1.1% |
| 2026 YTD | $64.3 | $60.2 | -6.4% |
SAH has finished higher in five of the last six years. It's down 6.4% so far in 2026.